Small RNAs-New Drug Development for Cardiovascular Diseases

来源 :Frontier of Medical Sciences,Forum 2011 & The 1th National C | 被引量 : 0次 | 上传用户:linmu22952
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Deregulated myocardial fibrosis is a major cause of cardiac dysfunction.The focus of this investigation was to elucidate the importance of miRNAs in the control of pathophysiological processes following cardiac fibrosis.Gain of function and loss of function approaches in a specific miRNA transgenic mouse models were employed in the present study.First, we found that the level of the miRNA is aberrantly upregulated in the border zone of infarcted heart of wild type (WT) mouse following cardiac fibrosis by occlusion of the left coronary artery (LCA).
其他文献
会议
会议
会议
会议
会议
会议
会议
会议
During last several years, the antiplatelet clopidogrel were hot topic areas of pharmacogenomics researches and its clinical relevance for the personalized pharmacotherapy.Genetic variants of CYP450 e
会议
We have been developing biochip technologies and products for 10 years in collaboration with leading research hospitals in China to satisfy unmet demands from hospital bedsides.The products that have
会议